Its shares are up 134% year-to-date. The stock soared in late February after the FDA backed its weight loss drug Qnexa. Arena also develops drugs for cardiovascular, central nervous system, inflammatory and metabolic diseases. Up 71% …
To read the entire report visit: www.microstockprofit.com/lp/VVUS See what investors are saying about VVUS at penny stock forum MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com …
Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a battle of not only who has the drug with the highest degree of efficacy, but …
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is VIVUS Inc. (VVUS). This Medical – Biomedical/Genetics stock has actually seen loss estimates narrow over the past month for …
VIVUS, Inc. (NASDAQ:VVUS) announced on Tuesday that it was going to raise capital in a shares sale for up to 8.5 million shares. We had written last week that we expected the company to raise capital any day. Demand must have …
VVUS). The firm only has the right to purchase shares in the future through options and contracts. Perry said using the word “may” in the filing raises some red flags. “People hold stock in certain ways for many reasons, be it liquidity, tax ...
VVUS): The maker of diet drug Qsymia is upgraded to Outperform from Market Perform at Cowen. As a result its shares, up 8.64% in yesterday's down market, are adding to gains ahead of the open. VMware (NYSE:VMW): FBN Securities …
Campbell, CA-based VIVUS, Inc. VVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet medical needs. The company's portfolio comprises two drugs, Qsymia for …
Investors can receive FREE Stock Alerts by visiting doubleinstocks.com at the following link: http://www.doubleinstocks.com Today's alerts include: Zamage Digital Art, Inc. (Other OTC: ZMGD.PK), VIVUS Inc. …
Infinera Corporation (NASDAQ: INFN) 13.5% HIGHER; reported Q4 EPS of $0.13, $0.02 better than the analyst …